Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer

Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer

Background: The prognosis of lymphnode positive breast cancer is worse than that of lymph node negative breast cancer but some cases may not require chemotherapy. We investigated the ability of the new multi-gene assays, 95GC and 155GC, to identify patients with lymphnode positive Luminal-type breas...

Full description

Bibliographic Details
Main Authors: Saya Matsumoto, Ryo Tsunashima, Sae Kitano, Akira Watanabe, Chikage Kato, Midori Morita, Koichi Sakaguchi, Balázs Győrffy, Yasuto Naoi
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Cancer Treatment and Research Communications
Subjects:
CurebestTM 95GC breast
155GC
Breast cancer
Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294223000321

Internet

http://www.sciencedirect.com/science/article/pii/S2468294223000321

Similar Items